Skip to Content
 
Center for International Blood and Marrow Transplant Research

PC20-01c

Main Content

Why are higher cd34+ cell doses associated with improved outcomes among pediatric patients undergoing autologous hematopoietic stem cell transplant for central nervous system tumors - but not for high-risk neuroblastoma?

Study #: PC20-01c

Study Status: Published

Why are higher cd34+ cell doses associated with improved outcomes among pediatric patients undergoing autologous hematopoietic stem cell transplant for central nervous system tumors - but not for high-risk neuroblastoma?

Citation

Knight TE, Broglie L, Sharma A, Qayed M, Yanik GA.

Journal of Pediatric Hematology/Oncology. 2025, Feb 01: 42(1): 42(1):63-67. doi: 10.1080/08880018.2024.2420924. Epub 2024, Nov 05. PMCID:PMC11745919.

PubMed

PMID: 39501613

Abstract